Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety a... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and ... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA)'... Read More
U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866482) titled 'Nano-Silver Versus Bioactive Glass for Primary Teeth Exposed to Therapeutic Radiation' on Oc... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD01... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. Th... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or wi... Read More
U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07865832) titled 'A Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma' ... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or wi... Read More
Singapore, Oct. 9 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-08634404 ... Read More